Multiple endocrine neoplasia in an orthodontic patient

• Published in: The Journal of the American Dental Association (1939) Vol. 143; no. 10; pp. 1093 - 1098
• Main Authors: Collins, Joanne M., MSc, MFDSRCS, MOrth, FDS(Orth)RCS(Eng), Chaudhry, Shahid I., FDSRCS, MRCP(UK), PhD, Gill, Daljit S., MSc, FDSRCS, MOrth, Porter FDS(Orth)RCS(Eng), Porter, Stephen R., MD, PhD, FDSRCS, FDSRCSE, FHEA
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.10.2012
• Subjects: Dentistry; medullary thyroid cancer; Multiple endocrine neoplasia; RET; C cells; MEN 2A; MEN 2B; Multiple endocrine neoplasia, type 2; Carcinoembryonic antigen; Multiple endocrine neoplasia; MEN 2; medullary thyroid cancer; Multiple endocrine neoplasia, type 2B; Rearranged during transfection; Multiple endocrine neoplasia, type 2A; MTC; Calcitonin-producing cells; CEA
• ISSN: 0002-8177; 1943-4723
• DOI: 10.14219/jada.archive.2012.0039

ABSTRACT Background Multiple endocrine neoplasia, type 2B (MEN 2B), is an autosomal-dominant condition characterized by the development of multiple endocrine tumors. All affected people develop an aggressive form of medullary thyroid cancer (MTC). Without early prophylactic thyroidectomy, the prognosis for patients with MEN 2B is poor; the average age at death is 21 years. Case Description The authors present a case of a 16-year-old girl who had a diagnosis of MEN 2B and was treated successfully for metastatic MTC. Clinical Implications Given the striking orofacial manifestations of MEN 2B (marfanoid habitus; dolichocephaly; everted and thickened lips; mucosal neuromas on lips, tongue, buccal mucosa and eyelids), dental professionals are well positioned to recognize the disorder. Early identification of patients with the condition permits screening for preclinical thyroid disease, molecular genetic testing, counseling and lifesaving thyroid surgery.